Verlukast

DB20044ExperimentalSmall molecule

Verlukast is a small molecule drug. The usage of the INN stem '-lukast' in the name indicates that Verlukast is a leukotriene receptor antagonist. Verlukast has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Cysteinyl leukotriene receptor 1
Curator reviewed
Formula / weight: C₂₆H₂₇ClN₂O₃S₂ · 515.08 g/mol (avg)
Code names: L-668,019 · MK-0679 · MK-679

Resolves to

Compound

UNII5Q9O54P0H7CAS120443-16-5ChEMBLCHEMBL280481

Structure

InChIKeyAXUZQJFHDNNPFG-LHAVAQOQSA-NSMILESCN(C)C(=O)CCS[C@H](SCCC(O)=O)C1=CC=CC(\C=C\C2=CC=C3C=CC(Cl)=CC3=N2)=C1

Targets

Q9Y271CYSLTR1

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Verlukast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account